A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease
NCT07566429
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
AB-1005
Sponsor
Bayer
Collaborators
[object Object]